🇺🇸 FDA
Patent

US 12220389

Combination therapy for the treatment of tinnitus and other medical conditions

granted A61KA61K31/137A61K31/138

Quick answer

US patent 12220389 (Combination therapy for the treatment of tinnitus and other medical conditions) held by The Regents of the University of California expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/137, A61K31/138, A61K31/195, A61K31/277